Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Nathan

Showing results (111-120 of 297) with videos related to

Pageof 30
Sort By:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 19, 2021
Does 1-minute walk test predict results of 6-minute walk test in patients with idiopathic pulmonary fibrosis?Flavia S Nunes, Jean Pastre, Anne W Brown, et al.
Respiration; International Review of Thoracic Diseases|August 17, 2018
Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician ViewsToby M Maher, Jeffrey J Swigris, Michael Kreuter, et al.
Respiratory Medicine|March 5, 2010
Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosisSteven D Nathan, Ashwin Basavaraj, Cristina Reichner, et al.
Respiratory Medicine|November 26, 2016
Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?Steven D Nathan, Jürgen Behr, Vincent Cottin, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|April 14, 2004
Mortality from time of listing for transplantation as an indicator of candidate outcomesSteven D Nathan, Scott D Barnett, Shahzad Ahmad, et al.
Respiration; International Review of Thoracic Diseases|January 25, 2008
Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosisSteven D Nathan, Oksana A Shlobin, Shahzad Ahmad, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 28, 2009
Native lung complications in single-lung transplant recipients and the role of pneumonectomyChristopher S King, Sandeep Khandhar, Nelson Burton, et al.
Chest|September 5, 2014
Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort studyA Whitney Brown, Chelsea P Fischer, Oksana A Shlobin, et al.
Advances in Therapy|August 12, 2019
Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisMarilyn K Glassberg, Steven D Nathan, Chin-Yu Lin, et al.
BMC Pulmonary Medicine|September 26, 2025
The effect of antifibrotics on the progression of pulmonary hypertension in patients with interstitial lung disease listed for lung transplantationChristopher Thomas, Abhimanyu Chandel, Mira Zineddin, et al.
Pageof 30

Showing results (111-120 of 297) with videos related to

Sort By:
Pageof 30
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 19, 2021
Does 1-minute walk test predict results of 6-minute walk test in patients with idiopathic pulmonary fibrosis?Flavia S Nunes, Jean Pastre, Anne W Brown, et al.
Respiration; International Review of Thoracic Diseases|August 17, 2018
Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician ViewsToby M Maher, Jeffrey J Swigris, Michael Kreuter, et al.
Respiratory Medicine|March 5, 2010
Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosisSteven D Nathan, Ashwin Basavaraj, Cristina Reichner, et al.
Respiratory Medicine|November 26, 2016
Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?Steven D Nathan, Jürgen Behr, Vincent Cottin, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|April 14, 2004
Mortality from time of listing for transplantation as an indicator of candidate outcomesSteven D Nathan, Scott D Barnett, Shahzad Ahmad, et al.
Respiration; International Review of Thoracic Diseases|January 25, 2008
Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosisSteven D Nathan, Oksana A Shlobin, Shahzad Ahmad, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 28, 2009
Native lung complications in single-lung transplant recipients and the role of pneumonectomyChristopher S King, Sandeep Khandhar, Nelson Burton, et al.
Chest|September 5, 2014
Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort studyA Whitney Brown, Chelsea P Fischer, Oksana A Shlobin, et al.
Advances in Therapy|August 12, 2019
Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisMarilyn K Glassberg, Steven D Nathan, Chin-Yu Lin, et al.
BMC Pulmonary Medicine|September 26, 2025
The effect of antifibrotics on the progression of pulmonary hypertension in patients with interstitial lung disease listed for lung transplantationChristopher Thomas, Abhimanyu Chandel, Mira Zineddin, et al.
Pageof 30